CEBEMYXINE

This brand name is authorized in France, Tunisia

Active ingredients

The drug CEBEMYXINE contains a combination of these active pharmaceutical ingredients (APIs):

1 Neomycin UNII 057Y626693 - NEOMYCIN SULFATE

Neomycin is an aminoglycoside antibiotic and acts by binding to polysomes, inhibiting protein synthesis and generating errors in the transcription of the genetic code. Read about Neomycin

2 Polymyxin B UNII 19371312D4 - POLYMYXIN B SULFATE

Polymixin B is bactericidal against a wide range of gram negative bacilli. It exerts a bactericidal effect by binding to acid phospholipids in the cell wall and membranes of the bacterium, thereby rendering ineffective the osmotic barrier normally provided by the cell membrane. Read about Polymyxin B

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01AA30	Combinations of different antibiotics	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AA Antibiotics
Discover more medicines within S01AA30

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: FR	Base de données publique des médicaments	Identifier(s): 62307903
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 5280042, 5280043